Почетна › Рак на дојка › Северна Каролина › Charlotte
Клинички испитувања за Рак на дојка во Charlotte, NC
22 студии за Рак на дојка бараат учесници на локации во и околу Charlotte (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Се регрутираФаза 2
- Levine Cancer, Charlotte
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Се регрутираФаза 1
- Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville · на 13 милји
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Се регрутираФаза 3
- Novant Health Cancer Institute ( Site 0019), Charlotte
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Се регрутираФаза 3
- Levine Cancer Institute ( Site 0014), Charlotte
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Се регрутираФаза 3
- Levine Cancer Institute, Charlotte
- Levine Cancer Institute, Charlotte
- Levine Cancer Institute, Charlotte
- и уште 7
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Се регрутира
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Се регрутира
- Atrium Levine Cancer Institute, Charlotte
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Се регрутираФаза 3
- Clinical Trial Site, Charlotte
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Се регрутираФаза 3
- Atrium Health, Charlotte
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Се регрутираФаза 3
- Oncology Specialists of Charlotte Pa, Charlotte
- Carolina Oncology Specialists, Charlotte
Utility of a Mobile Application for Young Women With Breast Cancer
Се регрутира
- Atrium Health Levine Cancer, Charlotte
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Се регрутираФаза 1/2
- Research Site, Charlotte
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Се регрутираФаза 1/2
- Levine Cancer Institute, Charlotte
- Novant Health Cancer Institute, Charlotte
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Се регрутираФаза 3
- Novant Health Cancer Institute, Charlotte
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Се регрутираФаза 3
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- и уште 12
E-Mindfulness Approaches for Living After Breast Cancer
Се регрутираФаза 3
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- Levine Cancer Institute-SouthPark, Charlotte
- и уште 7
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Се регрутираФаза 2
- GSK Investigational Site, Charlotte
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- Carolina BioOncology Institute, Huntersville · на 13 милји
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Се регрутираФаза 3
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- и уште 10
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Се регрутираФаза 1/2
- Levine Cancer Institute (LCI)- Atrium Health, Charlotte
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Се регрутираНабљудувачка студија
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- Levine Cancer Institute-SouthPark, Charlotte
- и уште 8
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Се регрутираНабљудувачка студија
- Atrium Health Levine Cancer Institute, Charlotte
- Novant Health Cancer Institute - Elizabeth, Charlotte
Испитувања за Рак на дојка во други градови
- New York City, NY136 студии
- Houston, TX126 студии
- Boston, MA112 студии
- Nashville, TN81 студија
- Los Angeles, CA73 студии
- Edison, NJ68 студии
- St. Louis, MO64 студии
- Queens, NY64 студии
- Durham, NC64 студии
- Chicago, IL59 студии
- Philadelphia, PA56 студии
- Dallas, TX55 студии
Други студии во Charlotte
- Рак (сите типови)27 студии
- Множен миелом21 студија
- Рак на бели дробови со не-мали клетки19 студии
- Акутна миелоидна леукемија16 студии
- Дебелина16 студии
- Прекумерна телесна тежина15 студии
- Колоректален карцином13 студии
- Карцином на јајниците12 студии
- Срцева слабост11 студии
- Метастатски карцином11 студии
- Сквамозноклеточен карцином на глава и врат10 студии
- ХОБП9 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.